Avestar Capital’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $989K | Sell |
14,155
-1,299
| -8% | -$90.8K | 0.07% | 188 |
|
|
2025
Q1 | $1.14M | Buy |
15,454
+27
| +0.2% | +$1.99K | 0.1% | 151 |
|
|
2024
Q4 | $1.01M | Buy |
15,427
+2,462
| +19% | +$161K | 0.09% | 151 |
|
|
2024
Q3 | $1.01M | Buy |
12,965
+447
| +4% | +$34.8K | 0.1% | 142 |
|
|
2024
Q2 | $976K | Buy |
12,518
+7,041
| +129% | +$549K | 0.1% | 136 |
|
|
2024
Q1 | $371K | Buy |
5,477
+615
| +13% | +$41.7K | 0.04% | 262 |
|
|
2023
Q4 | $327K | Buy |
4,862
+37
| +0.8% | +$2.49K | 0.04% | 258 |
|
|
2023
Q3 | $327K | Buy |
4,825
+96
| +2% | +$6.5K | 0.05% | 210 |
|
|
2023
Q2 | $338K | Buy |
4,729
+202
| +4% | +$14.5K | 0.05% | 188 |
|
|
2023
Q1 | $314K | Buy |
+4,527
| New | +$314K | 0.06% | 204 |
|
|
2021
Q4 | – | Sell |
-3,376
| Closed | -$203K | – | 347 |
|
|
2021
Q3 | $203K | Hold |
3,376
| – | – | 0.03% | 345 |
|
|
2021
Q2 | $202K | Buy |
+3,376
| New | +$202K | 0.03% | 344 |
|
|
2020
Q4 | – | Sell |
-5,890
| Closed | -$313K | – | 269 |
|
|
2020
Q3 | $313K | Buy |
+5,890
| New | +$313K | 0.1% | 152 |
|
|
2019
Q3 | – | Sell |
-2,293
| Closed | -$92K | – | 228 |
|
|
2019
Q2 | $92K | Hold |
2,293
| – | – | 0.06% | 204 |
|
|
2019
Q1 | $89K | Buy |
2,293
+645
| +39% | +$25K | 0.06% | 205 |
|
|
2018
Q4 | $59K | Buy |
1,648
+92
| +6% | +$3.29K | 0.04% | 242 |
|
|
2018
Q3 | $59K | Buy |
1,556
+476
| +44% | +$18K | 0.03% | 258 |
|
|
2018
Q2 | $34K | Sell |
1,080
-46
| -4% | -$1.45K | 0.02% | 304 |
|
|
2018
Q1 | $36K | Sell |
1,126
-279
| -20% | -$8.92K | 0.02% | 276 |
|
|
2017
Q4 | $46K | Buy |
+1,405
| New | +$46K | 0.03% | 257 |
|